Accelerated Corneal CXL for Keratoconus in Pediatric Patients: 1-Year Results

Ozgurhan, Engin

Accelerated Corneal CXL for Keratoconus in Pediatric Patients: 1-Year Results

Friday, April 25, 2014

KIOSKS (Boston Convention and Exhibition Center)

Engin B. Ozgurhan, MD, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey

Ugur Celik, MD, Beyoglu Eye Research and Training Hospital, ISTANBUL, Turkey

Ercument Bozkurt, Beyoglu Eye Research and Training Hospital, Istanbul, Turkey

Ahmet Demirok, MD, Beyoglu Eye Training and Research Hospital, Beyoglu, Turkey

Omer F. Yilmaz, MD Istanbul, Turkey

Narrative Responses:

Purpose
To evaluate the outcomes of accelerated corneal collagen cross-linking (CXL) in pediatric patients with keratoconus

Methods
The study was performed on 59 keratoconus eyes (54 participants: 38 M, 16 F, 9 to 18 years old) treated with accelerated collagen cross linking for corneal stabilization. Main outcome measures were best corrected visual acuity(BCVA), maximum K values (Kmax), and endothelial cell count.

Results
Preoperative and postoperative 3rd and 12th month visits were evaluated. The best corrected visual acuity values were 0.48±0.34(Log MAR), 0.47±0.38 and 0.47±0.41 respectively. Mean Kmax values were 58.02±5.03, 57.34±4.41 and 57.22±4.8 respectively.(p=0.714) Endothelial cell counts were 2494.4 ± 82.3 and 2486.0 ±109.7 and 2403 ±119.7 respectively.

Conclusion
Preliminary data of pediatric patients with keratoconus Show safe treatment results by Accelerated CXL. No per or postoperative complications was seen over 1 year.